5C1A — Esperite NV Income Statement

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual income statement for Esperite NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	C2013 December 31st	2014 December 31st	2015 December 31st	2016 December 31st	2017 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	29.8	27.6	27.5	26.3	16.6
Cost of Revenue
Gross Profit	19.2	17.2	14.8	14.7	10.9
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	33.3	32.7	35.1	35.2	26.3
Operating Profit	-3.45	-5.11	-7.55	-8.9	-9.77
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-3.48	-5.47	-8.07	-9.74	-12.9
Provision for Income Taxes
Net Income After Taxes	-3.51	-5	-7.21	-8.54	-12.9
Minority Interest
Net Income Before Extraordinary Items
Net Income	-3.51	-5.01	-7.06	-8.41	-12.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-3.51	-5.01	-7.06	-8.41	-12.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.111	-0.405	-0.703	-0.596	-0.811
Dividends per Share